Korlym is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Corcept Therapeutics. The primary component is Mifepristone.
Product ID | 76346-073_28cc1a6b-0671-4e82-8bcf-6008e7b2404e |
NDC | 76346-073 |
Product Type | Human Prescription Drug |
Proprietary Name | Korlym |
Generic Name | Mifepristone |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2012-02-17 |
Marketing Category | NDA / NDA |
Application Number | NDA202107 |
Labeler Name | Corcept Therapeutics |
Substance Name | MIFEPRISTONE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Progestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2014-10-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202107 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-01-10 |
Marketing Category | NDA |
Application Number | NDA202107 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-10-03 |
Ingredient | Strength |
---|---|
MIFEPRISTONE | 300 mg/1 |
SPL SET ID: | 542f3fae-8bc8-4f00-9228-e4b66c9ad6a9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
76346-073 | Korlym | Mifepristone |
43393-001 | Mifepristone | MIFEPRISTONE |
83114-001 | MIFEPRISTONE | mifepristone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KORLYM 90792899 not registered Live/Pending |
CORCEPT THERAPEUTICS INCORPORATED 2021-06-24 |
KORLYM 88976826 not registered Live/Pending |
CORCEPT THERAPEUTICS INCORPORATED 2019-01-30 |
KORLYM 88282423 not registered Live/Pending |
CORCEPT THERAPEUTICS INCORPORATED 2019-01-30 |
KORLYM 86699675 not registered Dead/Abandoned |
CORCEPT THERAPEUTICS, INC. 2015-07-21 |
KORLYM 85218444 4313527 Live/Registered |
Corcept Therapeutics, Inc. 2011-01-14 |